Back

The neuropathy-causing GARS1{triangleup}ETAQ mutation drives pathology in subsets of motor and sensory neurons in mice

Simkin, R. L.; Paulo-Ramos, A.; Lang, Q.; Rhymes, E. R.; Surana, S.; Villarroel Campos, D.; Liu, S.; Bellanti, R.; Veleva, E.; Drotsevitch, V.; Swann, O.; Heslegrave, A.; Zetterberg, H.; Lunn, M. P.; Burgess, R. W.; Sleigh, J. N.

2026-07-09 neuroscience
10.64898/2026.07.05.736541 bioRxiv
Show abstract

Charcot-Marie-Tooth disease type 2D (CMT2D) results from gain-of-function mutations in GARS1, which encodes glycyl-tRNA synthetase (GlyRS), the enzyme responsible for charging transfer RNA (tRNA) with glycine. There are several CMT2D mouse models, but Gars{Delta}ETAQ/+ is the only one that bears a patient-sourced mutation. Created using CRISPR/Cas9 to model a 12-nucleotide de novo GARS1 deletion identified in an unusually severe CMT2D patient, Gars{Delta}ETAQ/+ mice have previously been shown to display several neuromuscular phenotypes; motor axon loss, denervated neuromuscular junctions (NMJs) and reduced muscle function. Here, we extend these analyses to provide a more comprehensive understanding of both motor and sensory nerve deficits across hind- and fore-limbs. At 3 months, Gars{Delta}ETAQ/+ mice possess sex-independent alterations in the levels of neuropathy biomarkers - including decreased NfL and increased periaxin - alongside reduced muscle endurance and strength, and impairments in the sensory modalities of mechanosensation, proprioception and nociception. Underpinning these dysfunctions, we identified site-specific defects comprising altered sensory neuron populations, muscle spindle loss, reduced motor neuron size, disrupted NMJ innervation and maturation, and reduced axonal transport of signalling endosomes in vivo. Together, these experiments show that Gars{Delta}ETAQ/+ mice display robust and selective peripheral nerve pathology that manifests in a general distal-to-proximal fashion, priming this CMT2D allele for testing treatments and evaluating mechanisms underlying peripheral nerve vulnerability. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=200 SRC="FIGDIR/small/736541v1_ufig1.gif" ALT="Figure 1"> View larger version (70K): org.highwire.dtl.DTLVardef@2b25d2org.highwire.dtl.DTLVardef@c00d77org.highwire.dtl.DTLVardef@b41173org.highwire.dtl.DTLVardef@1e5cdcc_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
JCI Insight
277 papers in training set
Top 0.5%
7.7%
2
Journal of Clinical Investigation
179 papers in training set
Top 0.3%
7.7%
3
Cell Reports
1498 papers in training set
Top 5%
6.6%
4
Nature Communications
5641 papers in training set
Top 28%
5.3%
5
Nature
645 papers in training set
Top 3%
5.0%
6
Science Translational Medicine
127 papers in training set
Top 0.4%
4.3%
7
Cell
431 papers in training set
Top 2%
4.2%
8
Brain
168 papers in training set
Top 0.8%
4.2%
9
Acta Neuropathologica
58 papers in training set
Top 0.4%
3.9%
10
Movement Disorders
71 papers in training set
Top 0.4%
3.3%
50% of probability mass above
11
PLOS Genetics
862 papers in training set
Top 4%
3.2%
12
eLife
5828 papers in training set
Top 36%
3.1%
13
Nature Neuroscience
252 papers in training set
Top 2%
2.7%
14
EMBO Molecular Medicine
95 papers in training set
Top 0.4%
2.6%
15
Disease Models & Mechanisms
119 papers in training set
Top 0.8%
2.4%
16
Neurobiology of Disease
148 papers in training set
Top 2%
2.3%
17
Neuron
337 papers in training set
Top 3%
2.3%
18
Human Molecular Genetics
141 papers in training set
Top 1%
1.9%
19
PLOS ONE
5266 papers in training set
Top 50%
1.6%
20
Science Advances
1243 papers in training set
Top 23%
1.3%
21
Frontiers in Cellular Neuroscience
91 papers in training set
Top 1%
1.1%
22
Journal of Translational Medicine
57 papers in training set
Top 1%
1.1%
23
eneuro
439 papers in training set
Top 6%
1.1%
24
Science
477 papers in training set
Top 7%
1.1%
25
The American Journal of Human Genetics
234 papers in training set
Top 3%
1.0%
26
GENETICS
483 papers in training set
Top 4%
1.0%
27
Annals of Clinical and Translational Neurology
34 papers in training set
Top 1.0%
0.8%
28
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 43%
0.8%
29
PNAS Nexus
159 papers in training set
Top 4%
0.8%
30
eBioMedicine
183 papers in training set
Top 8%
0.6%